Chemotherapy-free Regimen of Venetoclax, Azacitidine Plus Orebatinib (VAO Regimen) for Newly Diagnosed ph+ALL
Clinical trial NCT06578546 · UNKNOWN
Trial details
- NCT number
- NCT06578546
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2025-02-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.